BPC 157 is back in the conversation as a potential peptide to improve musculoskeletal tissue repair. One registered Phase 1 trial in healthy volunteers exists for an oral formulation (NCT02637284) Brandon Roberts PharmaTher Supports Proposed U.S. Peptide Reclassification, Reinforcing the Strategic Value of Its Microneedle Patch Platforms for Peptide Delivery Stable Gastric Pentadecapeptide BPC 157 as a Therapy and Safety Key: A Special Beneficial Pleiotropic Effect Controlling and Modulating Angiogenesis and the NO System Peptide BPC 157 Las Vegas Sky Health Wellness Clinic The Peptide Plastic Surgeon: A Review of Evidence on Regenerative Peptide Supplementation and Potential in Aesthetic Plastic Sur